The investigators noted that the HYPERION trial had lost clinical equipoise based on robust evidence of clinical benefit from other trials. A phase 3 trial evaluating sotatercept-csrk (Winrevair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback